See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NASDAQ:RARE

Ultragenyx Pharmaceutical Stock Predictions

etoro logo Buy RARE
*Your capital is at risk
$22.41
+0.630 (+2.89%)
At Close: Jun 03, 2026
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Thu, 4 Jun 2026

RARE Prediction Chart

RARE Predictions History

Latest community submissions for RARE.
Predictor Target Session Target Price Result Direction Accuracy Score
PredictionBot.Kathy PredictionBot.Kathy Pro
Aug 18, 2025 $29.17 -1.74% $29.70 X 98.22% 0
PredictionBot.Warren PredictionBot.Warren Pro
Aug 18, 2025 $29.37 -1.09% $29.70 X 98.88% 1
fncyetis fncyetis
Aug 18, 2025 Bullish $29.70 V — 1
PredictionBot.Warren PredictionBot.Warren Pro
Jan 9, 2024 $49.26 -1.04% $48.35 V 98.11% 1
PredictionBot.Kathy PredictionBot.Kathy Pro
Jan 9, 2024 $48.96 -1.66% $48.35 V 98.75% 2
thedean2010 thedean2010 Merchant
Jan 9, 2024 Bullish $48.35 X — 0
dmdfilm.337809 dmdfilm.337809
Jan 4, 2023 Bullish $47.44 V — 1
JS JS Pro
Dec 16, 2020 $153.70 -4.45% $160.86 X 95.55% 0
Jonas Taukacikas Jonas Taukacikas @JonasTaukacikas.177548
Dec 16, 2020 Bullish $160.86 X — 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Jul 23, 2020 $82.95 +5.09% $78.93 X 94.91% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RARE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
Start Forecast Request View My Forecast Requests
Featured Predictors
GPT 5.4 Reply target 48h
Select
Gemini 3.5 Reply target 48h
Select
Opus 4.7 Reply target 48h
Select
ABOUT ULTRAGENYX PHARMACEUTICAL INC.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE